CLINICAL BENEFIT OF PELABRESIB (CPI-0610) IN COMBINATION WITH RUXOLITINIB IN JAK INHIBITOR TREATMENT NAÏVE MYELOFIBROSIS PATIENTS: INTERIM EFFICACY SUBGROUP ANALYSIS FROM ARM 3 OF MANIFEST PH2 STUDY

EHA Library, Marina Kremyanskaya, 324808

A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET)

EHA Library, David Ross, 324809

SAFETY AND EFFICACY OF MEPOLIZUMAB IN HYPEREOSINOPHILIC SYNDROME: AN OPEN-LABEL EXTENSION STUDY

EHA Library, Florence Roufosse, 324810

INCREASED RISK OF PRETERM BIRTH IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS – A POPULATION BASED COHORT STUDY FROM SWEDEN

EHA Library, Anna Ravn Landtblom, 324811

LONG-TERM FOLLOW-UP OF RECOVERED MPN PATIENTS WITH COVID-19

EHA Library, Tiziano Barbui, 324812

AN EPIDEMIOLOGICAL STUDY OF THE CARDIOVASCULAR HEALTH AND THROMBOTIC RISK PROFILES OF PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS IN PRIMARY CARE ACROSS THE UNITED KINGDOM

EHA Library, Frederick Chen, 324813

ANALYSIS OF THROMBOTIC AND BLEEDING COMPLICATIONS IN 1381 ESSENTIAL THROMBOCYTHEMIA PATIENTS ASSESSED BY R-IPSET THROMBOSIS RISK SCORE: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Marta Sobas, 324814

IMPACT OF BONE MARROW FIBROSIS GRADE ON RESPONSE AND OUTCOME IN PATIENTS WITH PRIMARY MYELOFIBROSIS TREATED WITH RUXOLITINIB: A POST-HOC ANALYSIS OF THE JUMP STUDY

EHA Library, Francesca Palandri, 324815

CLINICAL AND MOLECULAR FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS

EHA Library, Aniket Bankar, 324816

WHEN MYELOPROLIFERATIVE NEOPLASMS MEET COVID-19: INFLAMMATION, ENDOTHELIOPATHY AND COAGULOPATHY

EHA Library, Rossella Cacciola, 324817

FIRST REAL-LIFE RESULTS ON PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH MIDOSTAURIN IN FRANCE

EHA Library, Julien Rossignol, 324818

OVERALL AND CAUSE SPECIFIC CHANGES IN MORTALITY OF PATIENTS WITH MYELOFIBROSIS OVER THE LAST 3 DECADES

EHA Library, Lucia Masarova, 324819

ACQUIRED VON WILLEBRAND SYNDROME IN MYELOPROLIFERATIVE NEOPLASMS WITH EXTREME THROMBOCYTOSIS

EHA Library, Chiara Trotti, 324820

INFECTIOUS AND THROMBOTIC COMPLICATIONS AND THEIR PROGNOSTIC IMPACT IN PATIENTS WITH CONCOMITANT MYELOID AND LYMPHOID NEOPLASMS. A SINGLE-CENTER COHORT STUDY

EHA Library, Cristina Bucelli, 324821

MYELOPROLIFERATIVE NEOPLASMS IN PEDIATRICS AND YOUNG ADULTS: GENOMIC FEATURES, CLINICAL OUTCOMES, PROGRESSION AND OVERALL SURVIVAL

EHA Library, Zoey Harris, 324822

HEMORRHAGIC EVENTS BUT NOT THROMBOTIC EVENTS CONTRIBUTE TO WORSE SURVIVAL IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A RETROSPECTIVE NATIONWIDE SURVEY IN JAPAN

EHA Library, Yoshinori Hashimoto, 324823

JAK2V617F ALLELE BURDEN: AN INDEPENDENT PREDICTOR OF OVERT FIBROSIS IN PRIMARY MYELOFIBROSIS

EHA Library, Sara Duarte, 324824

CLONAL MUTATION PATTERNS OF ESSENTIAL THROMBOCYTHEMIA REVEALED BY SINGLE-CELL TARGETED SEQUENCING

EHA Library, Rongfeng Fu, 324825

RECURRENT ACTIVATING STAT5B N642H MUTATION IN MYELOID NEOPLASMS: CLINICO-PATHOLOGIC AND GENOMIC CHARACTERIZATION

EHA Library, Huan Mo, 324826

A NATIONWIDE SURVEY OF JAPANESE PATIENTS WITH POLYCYTHEMIA VERA

EHA Library, Yoko Edahiro, 324827

IMETELSTAT DEMONSTRATES AN ACCEPTABLE SAFETY PROFILE IN MYELOID MALIGNANCIES

EHA Library, John Mascarenhas, 324828

HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A NATIONWIDE MATCHED COHORT STUDY

EHA Library, Sarah Christensen, 324829

ASSOCIATION OF JAK2 AND PHD2 MUTATIONS IN A FAMILY WITH ERYTHROCYTOSIS

EHA Library, Giacomo Biagetti, 324830

DIAGNOSTICS OF ERYTHROCYTOSIS OFTEN STOPS AFTER POLYCYTHAEMIA VERA EXCLUSION

EHA Library, Saša Anžej Doma, 324831

IS MIR-155 USEFUL AS A MARKER OF CLONAL HEMOPOESIS IN MYELOID PROLIFERATION?

EHA Library, Marina Stolyar, 324832

A REAL-WORLD STUDY ON DIAGNOSIS AND TREATMENT STRATEGIES OF PEDIATRIC ESSENTIAL THROMBOCYTHEMIA IN CHINA

EHA Library, Rongfeng Fu, 324833

EFFECT OF DRIVER MUTATIONS ON THE PHENOTYPE OF ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS

EHA Library, Gabdulkhakova Alfia, 324834

ACUTE CORONARY SYNDROME AND JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS: A CARDIOLOGICAL PERSPECTIVE

EHA Library, Siliva Cantoni, 324835

IPSS, DIPSS AND DIPSS-PLUS: PREDICTIVE VALUE FOR SURVIVAL IN PRIMARY MYELOFIBROSIS STAGES

EHA Library, Rita S Gomes, 324836

A POSSIBLE SYNERGISTIC EFFECT OF P SELECTIN GLYCOPROTEIN LIGAND 1 POLYMORPHISM AND ANTIPHOSHOLIPID ANTIBODIES ON THROMBOSIS IN MYELOPROLIFERATIVE NEOPLASIA PATIENTS

EHA Library, Ruta Dambrauskiene, 324837

CHARACTERIZATION OF MYELOID MUTATIONS IN 21 PATIENTS WITH COEXISTING MYELOPROLIFERATIVE AND LYMPHOPROLIFERATIVE SYNDROMES

EHA Library, Dolly Viviana Fiallo Suárez, 324838

PULMONARY MANIFESTATIONS OF ERDHEIM-CHESTER DISEASE：CLINICAL CHARACTERISTICS, OUTCOMES AND COMPARISON WITH LANGERHANS CELL HISTIOCYTOSIS

EHA Library, Ji-nuo Wang, 324839

THE ROLE OF NEUTROPHIL LYMPHOCYTE RATIO AND PLATELET LYMPHOCYTE RATIO AS AN INDICATOR TO THROMBOSIS IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: PRELIMINARY DATA OF PROSPECTIVE COHORT

EHA Library, Maha Abdelaziz, 324840

RUXOLITINIB-ASSOCIATED TUBERCULOSIS IN MYELOPROLIFERATIVE NEOPLASMS (MPN): SYSTEMATIC REVIEW AND META-ANALYSIS OF 26 CASE REPORTS

EHA Library, Mihnea-Alexandru Găman, 324841

VARIABLES ASSOCIATED WITH PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Qian Jiang, 324842

USE OF RUXOLITINIB IN ELDERLY PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, Sara Duarte, 324843

THE INCREASING INCIDENCE AND PREVALENCE OF HYPEREOSINOPHILIC SYNDROME (HES) IN THE UK

EHA Library, Gema Requena, 324844

INTERLEUKIN-6 AND ITS RELATION TO CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH MYELOFIBROSIS

EHA Library, Stela Dimitrova, 324845

THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) INCREASE T REGULATORY AND T HELPER CELLS IN SPLEENS OF PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Marco Pizzi, 324846

OFF-LABEL USE OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA BEFORE SIX MONTHS OF DISEASE DURATION IN THE REAL-WORLD IN FRANCE. RESULTS OF THE ELEXTRA STUDY.

EHA Library, Guillaume Moulis, 324847

EFFECTIVENESS OF ROMIPLOSTIM ON PLATELET ENDPOINTS AMONG PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA IN ROUTINE CLINICAL PRACTICE IN DENMARK, SWEDEN, AND NORWAY

EHA Library, Christian Fynbo Christiansen, 324848

OFF-LABEL USE OF ELTROMBOPAG IN A PEDIATRIC POPULATION WITH NEWLY-DIAGNOSED/PERSISTENT IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Giulia Ceglie, 324849

CLINICAL-PATHOLOGICAL PREDICTORS OF SPLENECTOMY RESPONSE IN PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTI-CENTER ITALIAN STUDY.

EHA Library, Marco Pizzi, 324851

TREATMENT OF IMMUNE THROMBOCYTOPENIA IN THE COVID-19 ERA: FOSTAMATINIB, AN ORAL SPLEEN TYROSINE KINASE INHIBITOR

EHA Library, Nichola Cooper, 324852

APPLICATION OF HIGH-THROUGHPUT SEQUENCING TO IDENTIFY COPY NUMBER VARIATIONS IN INHERITED PLATELET DISORDERS

EHA Library, Sandra Santos, 324853

CLINICAL APPLICATION OF GENETIC TESTING IN PATIENTS WITH NOT ACQUIRED THROMBOCYTOPENIA: ONE CENTER EXPERIENCE

EHA Library, Pablo Silva de Tena, 324854

COGNITIVE IMPAIRMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Camelia Vladescu, 324855

EFFECTIVENESS AND SAFETY OF ROMIPLOSTIM AMONG PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC ITP IN ROUTINE CENTRAL AND EASTERN EUROPEAN CLINICAL PRACTICE: AN ANALYSIS OF THE PLATON STUDY

EHA Library, Barbara Skopec, 324856

UNUSUAL LABORATORY FEATURES AND CLINICAL COURSE OF HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIOPULMONARY PATIENTS.

EHA Library, Manzoor Mangi, 324857

CAPLACIZUMAB FOR ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA: A SINGLE-INSTITUTION EXPERIENCE

EHA Library, Constantine Logothetis, 324858

BICYTOPENIA AND PANCYTOPENIA IN NEONATES: PREVALENCE, RISK FACTORS, AND OUTCOME

EHA Library, Hale Oren, 324859

IMMUNE THROMBOCYTOPENIA AND COVID-19: A SINGLE CENTRE EXPERIENCE

EHA Library, Marta Moreno Carbonell, 324860

PHARMACOKINETIC EVALUATION OF ELTROMBOPAG IN A COHORT OF PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Francesca de Gennaro, 324861

EFFICACY OF THROMBOPOIETIN RECEPTOR AGONISTS IN EVANS SYNDROME: A SINGLE CENTER SERIES

EHA Library, Nicola Cecchi, 324862

ELTROMBOPAG PLUS RHTPO VERSUS ELTROMBOPAG FOR ITP DURING THE COVID-19 PANDEMIC (ELABORATE-19)

EHA Library, Zhuo-Yu An, 324863

IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH LYMPHOID MALIGNANCIES: REPORT FROM A FRENCH PROSPECTIVE REGISTER.

EHA Library, Sylvain Audia, 324864

A MULTICENTER U.S. STUDY OF AVATROMBOPAG SWITCH THERAPY FOLLOWING PRIOR ELTROMBOPAG OR ROMIPLOSTIM

EHA Library, Hanny Al-Samkari, 324865

EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS

EHA Library, Ayoade Adeyemi, 324866

STYDY OF FAS, CASPASE-8 (CASP8) AND -10 (CASP10) POLYMORPHISMS IN CHILDREN AND ADOLESCENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Evangelia-Dimitra Ampazoglou, 324867

DARATUMUMAB, AN ORIGINAL APPROACH FOR TREATING REFRACTORY AUTOIMMUNE CYTOPENIA

EHA Library, Etienne Crickx, 324868

DURABILITY OF PLATELET COUNT RESPONSE IN PATIENTS TREATED WITH AVATROMBOPAG FOR IMMUNE THROMBOCYTOPENIA (ITP): POST-HOC RESULTS FROM THE PHASE 3 CORE AND OPEN-LABEL EXTENSION STUDY

EHA Library, Michael Vredenburg, 324869

SERUM COMPLEMENT LEVELS IN IMMUNE THROMBOCYTOPENIA: RELATION WITH CLINICAL PRESENTATION AND TREATMENT RESPONSE.

EHA Library, Sandra Pérez-León, 324870

GEOGRAPHIC DISTRIBUTION OF PATIENT AND PHYSICIAN ITP TREATMENT PREFERENCES AND EFFECT OF PHYSICIAN CASELOAD ON TREATMENT PRACTICES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, Nichola Cooper, 324871

LENGTH OF THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) TREATMENT AND PERSISTENCE IN IMMUNE THROMBOCYTOPENIA (ITP): REAL WORLD UNITED STATES CLAIMS ANALYSES

EHA Library, Michael Vredenburg, 324872

IMMUNE THROMBOCYTOPENIA DURING COVID-19 PANDEMIC: AN ITALIAN MONOCENTRIC EXPERIENCE

EHA Library, Gianfranco Lapietra, 324873

IMPACT OF AUTOIMMUNE ANTIBODIES IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: REAL WORLD RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

EHA Library, Charalampos Pontikoglou, 324874

SLEEP HEALTH IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: QUALITY OF LIFE DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION (PDSA) PATIENT REGISTRY

EHA Library, Jennifer MacWhirter-DiRaimo, 324875

ASSOCIATION OF IMMUNE THROMBOCYTOPENIA AND INFLAMMATORY BOWEL DISEASE IN CHILDREN

EHA Library, Angela Guarina, 324876

DEVELOPMENT AND VALIDATION OF THE C-SCORE, A SCORE OF DIAGNOSIS A SEVERE THROMBOCYTOPENIA OR OTHER CYTOPENIAS IN HEPATIC CIRRHOSIS

EHA Library, Felix Gibrant Marquez Villegas, 324877

EFFECTIVENESS AND SAFETY OF ROMIPLOSTIM IN PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA IN GERMAN ROUTINE CLINICAL PRACTICE: THE OBSERVATIONAL PLATEAU STUDY

EHA Library, Marcel Reiser, 324878

ASSOCIATION OF IMMUNE THROMBOCYTOPENIA AND COELIAC DISEASE IN CHILDREN

EHA Library, Angela Guarina, 324879

EPIDEMIOLOGY AND MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN ADULT PATIENTS IN ALGERIA

EHA Library, Mohamed Amine Bekadja, 324880

THE CLINICAL UTILITY OF ALINITY HQ STANDARD AND RESEARCH CBC PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF ITP

EHA Library, Sang Mee Hwang, 324881

CHANGES IN THE EXPRESSION OF PROTEINS INVOLVED IN THE CA2+ HOMEOSTASIS IN NEONATE PLATELETS.

EHA Library, Pedro C Redondo, 324882

PERSISTENT CLINICALLY IMPORTANT OUTCOMES OF FATIGUE, NEUROPATHY AND PROBLEMS WITH DAILY FUNCTIONING AMONG INDOLENT NON-HODGKIN LYMPHOMA SURVIVORS.

EHA Library, Afke Ekels, 324883

QUALITY OF LIFE WITH REGN5458 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PATIENT-REPORTED OUTCOMES (PROS) FROM THE FIRST-IN-HUMAN PHASE 1/2 TRIAL

EHA Library, Naresh Bumma, 324884

LOCAL SAFETY STANDARDS FOR INVASIVE PROCEDURES (LOCSSIPS) IN HAEMATOLOGY

EHA Library, Zeba Ahmed, 324885

SYSTEMATIC LITERATURE REVIEW (SLR) OF THE EFFICACY AND SAFETY OF SECOND-LINE (2L) TREATMENTS FOR RELAPSED OR REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Fei Fei Liu, 324886

ERECTILE DYSFUNCTION (ED) IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS (AL): DIAGNOSIS AND CORRELATION WITH THE HEMATOLOGIC DISEASE.

EHA Library, Claudia Giordano, 324887

COST-EFFECTIVENESS ANALYSIS OF AXICABTAGENE CILOLEUCEL VS TISAGENLECLEUCEL FOR THE MANAGEMENT OF DIFFUSE LARGE B-CELL LYMPHOMA IN SPAIN

EHA Library, Carlos Pardo, 324888

IMPLEMENTATION OF A HOSPITAL-AT-HOME (HAH) UNIT FOR HEMATOLOGICAL PATIENTS DURING THE COVID-19 PANDEMIC: SAFENESS AND FEASIBILITY.

EHA Library, Ignacio Gómez-Centurión, 324889

USE OF CHIMERIC ANTIGEN RECEPTOR T CELL THERAPIES IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN THE REAL-WORLD SETTING: SYSTEMATIC LITERATURE REVIEW

EHA Library, Fei Fei Liu, 324890

OUR EXPERIENCE OF NEGATIVE SYNERGISM BETWEEN STEROIDS AND LMWH IN PATIENTS WITH AGGRESSIVE LNH ON SKELETAL EVENTS (BONE FRACTURES)

EHA Library, MATTEO D'ADDONA, 324891

LANDSCAPE REVIEW OF THE PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) IN ONCOLOGY: ADOPTION AND RECENT LEARNINGS

EHA Library, Antoine Regnault, 324892

THE PSYCHOSOCIAL IMPACT OF HAEMATOPOIETIC STEM CELL TRANSPLANTATION ON ADULT PATIENTS WITH LYMPHOMA, LEUKAEMIA OR MYELODYSPLASTIC SYNDROMES – A LITERATURE REVIEW

EHA Library, Pauline Frank, 324893

COST EFFECTIVENESS COMPARISON OF BELANTAMAB MAFODOTIN AND SELINEXOR IN RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, ANKIT KANSAGRA, 324894

COST-EFFECTIVENESS OF ZANUBRUTINIB VERSUS IBRUTINIB IN ADULT PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jorge Castillo, 324895

QUANTIFYING PATIENT PREFERENCES FOR TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: A DISCRETE-CHOICE EXPERIMENT

EHA Library, Bradley Mason, 324896

A NEW OPTION IN PAIN PREVENTION WITH BLISS©, A THERAPEUTIC VIRTUAL REALITY SOLUTION IN BONE MARROW CONTEXT: RESULTS OF A FRENCH OPEN-LABEL MULTICENTER RANDOMIZED PHASE II/III STUDY (REVEH TRIAL)

EHA Library, Katell Le Dû, 324897

A CROSS-SECTIONAL STUDY EXAMINING THE IMPACT OF AGEING ON THE PSYCHOSOCIAL EXPERIENCES OF PATIENTS WITH LYMPHOMA

EHA Library, Natalie Dren, 324898

TARGETED LANDSCAPE REVIEW FOR UNDERSTANDING LYMPHOMA PATIENT-REPORTED OUTCOME ASSESSMENT IN THE ERA OF EMERGING THERAPIES

EHA Library, Stacie Hudgens, 324899

CLINICALLY IMPORTANT CHANGE IN FACIT-FATIGUE SCORE FOR PATIENTS WITH COLD AGGLUTININ DISEASE: AN ANALYSIS USING THE PHASE 3 CARDINAL AND CADENZA STUDIES

EHA Library, Quentin A Hill, 324900

INCREASED ANTIDEPRESSANT USE AMONG NEWLY DIAGNOSED PATIENTS WITH COLD AGGLUTININ DISEASE COMPARED WITH OTHER PATIENTS IN A LARGE US HEALTHCARE SYSTEM

EHA Library, Catherine Broome, 324901

A MACHINE LEARNING APPROACH TO IDENTIFICATION OF CLINICALLY RELEVANT HEMATOLOGY-ONCOLOGY RESEARCH PUBLICATIONS

EHA Library, Alexander Luchinin, 324902

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS) IN THE CONNECT® MYELOID DISEASE REGISTRY

EHA Library, Dennis A. Revicki, 324903

PROSPECTIVE COMPARISON OF POINT-OF-CARE INR VERSUS PLASMA INR IN SUPRA-THERAPEUTIC INR VALUES

EHA Library, Maria Angustias Molina Arrebola, 324904

FERTILITY PRESERVATION IN LYMPHOMA PATIENTS TREATED WITH IMMUNOCHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FERTY CARE).

EHA Library, Ombretta Annibali, 324905

IMPACT OF THE COVID-19 PANDEMIC ON HEALTH-RELATED QUALITY OF LIFE AND ANXIETY IN PEDIATRIC HEMATOLOGY/ONCOLOGY PATIENTS: A SINGLE EGYPTIAN CENTER EXPERIENCE

EHA Library, Yasmine El Chazli, 324906

THE IMPACT OF COVID-19 ON A RURAL HEMATOLOGY OUTREACH SERVICE, AN AUSTRALIAN EXPERIENCE

EHA Library, Helen Cashman, 324907

APPRAISAL OF THE CONSISTENT USE AND REPORTING OF PATIENT-REPORTED OUTCOMES IN MULTIPLE MYELOMA CLINICAL TRIALS: DOES IT MATTER?

EHA Library, Sam Salek, 324908